The Second Kunitz Domain of Human Tissue Factor Pathway Inhibitor: Cloning, Structure Determination and Interaction with Factor Xa

By Burgering M.J.M.   Orbons L.P.M.   van der Doelen A.   Mulders J.   Theunissen H.J.M.   Grootenhuis P.D.J.   Bode W.   Huber R.   Stubbs M.T.  

Journal of Molecular Biology, Vol. 269, Iss. 3, 1997-06 ,pp. : 395-407

Academic Press

Access to resources Recommend Favorite

Computer-aided design of a factor Xa inhibitor by using MCSS functionality maps and a CAVEAT linker search

By Takano Y.   Koizumi M.   Takarada R.   Takimoto Kamimura M.   Czerminski R.   Koike T.  

Journal of Molecular Graphics and Modelling, Vol. 22, Iss. 2, 2003-11 ,pp. : 105-114

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of BAY 59-7939 – an oral, direct Factor Xa inhibitor – in rats and dogs

By Weinz C.   Buetehorn U.   Daehler H.-P.   Kohlsdorfer C.   Pleiss U.   Sandmann S.   Schlemmer K.-H.   Schwarz T.   Steinke W.  

Xenobiotica, Vol. 35, Iss. 9, 2005-09 ,pp. : 891-910

Informa Healthcare

Access to resources Recommend Favorite

Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells

By Jin Hong   Lin Jijin   Fu Lu   Mei Yi-Fang   Peng Geng   Tan Xuerui   Wang Dong-Ming   Wang Wei   Li Yu-Guang  

Biochemistry and Cell Biology, Vol. 85, Iss. 2, 2007-04 ,pp. : 246-251

NRC Research Press

Access to resources Recommend Favorite

Prokaryotic Expression, Purification, and Reconstitution of Biological Activities (Antiprotease, Antitumor, and Heparin-Binding) for Tissue Factor Pathway Inhibitor-2

By Rao C.N.   Reddy P.   Reeder D.J.   Liu Y.   Stack S.M.   Kisiel W.   Woodley D.T.  

Biochemical and Biophysical Research Communications, Vol. 276, Iss. 3, 2000-10 ,pp. : 1286-1294

Elsevier

Access to resources Recommend Favorite